Novavax To Present RSV Vaccine Clinical Data At The 8th Vaccine & ISV Congress In Philadelphia On Sunday, October 26
October 23, 2014 at 16:31 PM EDT
Novavax, Inc. (Nasdaq: NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of ...
